Pokrovskaya Anastasia, Popova Anna, Ladnaya Natalia, Yurin Oleg
Central Scientific Research Institute of Epidemiology, Russian Federal AIDS Centre, Moscow, Russian Federation.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19506. doi: 10.7448/IAS.17.4.19506. eCollection 2014.
The cascade of HIV care is one of the main tools to assess the individual and public health benefits of antiretroviral therapy (ART) and identify barriers of treatment as prevention (TasP) concept realization. We aimed to characterize the changes in engagement of HIV-positive persons in care in Russia during three years (2011-2013).
We defined seven steps in the cascade of care framework: HIV infected (estimation data), HIV diagnosed, linked to HIV care, retained in HIV care, need ART, on ART and viral suppressed (VL < 1000 copies/mL during 12 month ART). Information was extracted from the Federal AIDS Centre database and from the national monitoring forms of Rospotrebnadzor from the beginning of 2011 to 31 December 2013.
Nearly 668,032 HIV-diagnosed Russian residents were alive by the end of 2013, which consisted 49% of the estimated 1,363,330 people living with HIV. Among the alive HIV-diagnosed patients, 516,403 (77%) were linked to care and 481,783 (72%) were retained. Of 163,822 (25% of HIV diagnosed) patients who were eligible for ART, 156,858 (96%) were on treatment while 127,054 (81%) had viral suppression. However, only 19% of HIV-diagnosed patients achieved viral suppression which is necessary to prevent viral transmission. We noted substantial improvements over time in the proportion of individuals on ART. The proportion of patients who received ART increased from 24% in 2011 to 34% in 2013. The most significant leakages of patients during three years were on steps: "HIV infected → HIV diagnosed" (loss -55% in 2011, -53% in 2012, and -51% in 2013), "HIV diagnosed → Linked to care" (-23% yearly) and "Retained in care → Need ART" (-76%, -70%, and -66%, respectively).
The stages of HIV diagnosis and estimation of ART eligibility were the most vulnerable to leakage. Encouraging HIV testing and earlier ART initiation are needed to maximize the effects of TasP interventions and to contain the spread of HIV in Russia.
艾滋病病毒治疗级联是评估抗逆转录病毒疗法(ART)对个人和公共健康益处以及确定治疗即预防(TasP)概念实施障碍的主要工具之一。我们旨在描述俄罗斯2011年至2013年三年间艾滋病病毒阳性者接受治疗情况的变化。
我们在治疗级联框架中定义了七个步骤:感染艾滋病病毒(估计数据)、确诊艾滋病病毒、与艾滋病病毒治疗机构建立联系、持续接受艾滋病病毒治疗、需要接受抗逆转录病毒治疗、正在接受抗逆转录病毒治疗且病毒得到抑制(接受抗逆转录病毒治疗12个月期间病毒载量<1000拷贝/毫升)。信息取自联邦艾滋病中心数据库以及俄罗斯联邦消费者权益保护和公益监督局2011年初至2013年12月31日的国家监测表格。
到2013年底,近668,032名确诊感染艾滋病病毒的俄罗斯居民存活,占估计的1,363,330名艾滋病病毒感染者的49%。在存活的确诊感染艾滋病病毒患者中,516,403人(77%)与治疗机构建立了联系,481,783人(72%)持续接受治疗。在163,822名符合抗逆转录病毒治疗条件的患者(占确诊感染艾滋病病毒者的25%)中,156,858人(96%)正在接受治疗,127,054人(81%)病毒得到抑制。然而,只有19%的确诊感染艾滋病病毒患者实现了病毒抑制,而这是预防病毒传播所必需的。我们注意到随着时间推移,接受抗逆转录病毒治疗的个体比例有显著改善。接受抗逆转录病毒治疗的患者比例从2011年的24%增至2013年的34%。三年间患者流失最严重的环节是:“感染艾滋病病毒→确诊艾滋病病毒”(2011年流失率为-55%,2012年为-53%,2013年为-51%)、“确诊艾滋病病毒→与治疗机构建立联系”(每年-23%)以及“持续接受治疗→需要接受抗逆转录病毒治疗”(分别为-76%、-70%和-66%)。
艾滋病病毒诊断阶段和抗逆转录病毒治疗资格评估阶段最容易出现流失情况。需要鼓励艾滋病病毒检测并尽早开始抗逆转录病毒治疗,以最大限度发挥治疗即预防干预措施的效果,并遏制俄罗斯艾滋病病毒的传播。